Dulaglutide - Eli Lilly and Company
At a glance
- Drug Originator Eli Lilly and Company
- Drug Licenced by Cipla; Sumitomo Pharma
- Drug Class Antihyperglycaemics; Glucagon-like peptides; Immunoglobulin Fc fragments; Recombinant fusion proteins
- Mechanism of Action Glucagon-like peptide-1 receptor agonists
- USA Patent Applicants ELI LILLY AND CO
- USA Patents 48
- BLAs 1
- International Patents 896
Disclaimer